EP2536752
Modified recombinant Factor VIII
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
9.2.2011EP published:
8.4.2015EP application number:
11708419.4
EPO information:
European Patent Register
Max expiry date:
8.2.2031
Title:
Modified recombinant Factor VIII
Timeline
Today
9.2.2011EP application
8.4.2015EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880, Bagsværd, DK
Inventor
Name:
BUCHARDT, JensAddress:
Gentofte, DK
Name:
BEHRENS, CarstenAddress:
København N, DK
Priority
Number:
305723 PDate:
18.2.2010Country:
US
Number:
10153716Date:
16.2.2010Country:
EP
Classification
Categories:
C07K 14/755, A61K 47/14